D
Denali Therapeutics Inc. DNLI
$15.49 $0.261.71% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 6.66% -15.87% -7.05% -8.25% 2.73%
Total Depreciation and Amortization 23.16% 160.82% -332.75% 16.84% -10.18%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 6.70% -21.51% 66.94% 10.05% 666.28%
Change in Net Operating Assets 206.17% -307.80% -65.22% 471.99% 48.39%
Cash from Operations 42.73% -57.04% -41.56% 35.17% 19.71%
Capital Expenditure 15.75% 0.27% -31.10% 18.85% -122.60%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 580.82% -86.56% 81.77% -5.63% 122.91%
Cash from Investing 742.41% -89.11% 83.87% -4.99% 121.75%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 44.14% 47.65% 65.34% -- --
Issuance of Common Stock 581.85% -85.68% -30.00% -12.14% -98.65%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 100.00% -- 100.00%
Cash from Financing 143.14% 9.74% 77.54% -374.70% -98.65%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 172.34% -238.14% 428.45% 13.13% 121.20%